Breaking News

1 day ago: Community Picnic & Underground Railroad Program at Schubert Woods Pavilion
2 weeks ago: Park Forest’s Sandra Zoellner Retires After 21 Years of Service
2 weeks ago: Save the date for The Prairie Party at theNate
2 weeks ago: Governors State Has New Soccer Complex and New Men’s Coach
3 weeks ago: Wilmington Man’s Photo of Rare Snowy Egret Wins Forest Preserve Photo Contest

(Logos by Sanofi)

Health and Fitness

FDA Approves Admelog, the First Short-acting “Follow-on” Insulin Product to Treat Diabetes

by eNews Park Forest on December 11, 2017

eNews Park Forest Author

More in Health and Fitness:

On Hantavirus, Park Forest Officials Urge Caution May 18, 2026
Rep. Kelly Condemns FDA Approval of Flavored E-Cigarettes May 6, 2026
Park Forest Aligns With Illinois Guidance on Childhood Vaccines Amid Federal Changes January 11, 2026

Admelog — (Logos by Sanofi)